98-23199. Availability of Exclusive Licensing of U.S. Patent Concerning Vaccine Against Ricin Toxin

[Federal Register Volume 63, Number 167 (Friday, August 28, 1998)]
[Notices]
[Page 46004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23199]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability of Exclusive Licensing of U.S. Patent Concerning 
Vaccine Against Ricin Toxin

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 5,453,271, entitled 
``Vaccine against ricin toxin,'' issued September 26, 1995. This patent 
has been assigned to the United States of America as represented by the 
Secretary of the Army.

ADDRESSES: Office of the Command Judge Advocate, U.S. Army Medical 
Research and Materiel Command, 504 Scott Street, Fort Detrick, Maryland 
21702-5012, ATTN: MCMR-JA.

FOR FURTHER INFORMATION CONTACT: Ms. Elizabeth Arwine, Attorney 
Advisor, [phone] or fax [phone].

SUPPLEMENTARY INFORMATION: This invention is a method for immunizing 
susceptible mammals to the pathological effects of exposure to ricin 
toxin. This immunization occurs by administration of a composition of 
matter comprising an antigenic effective amount of ricin A chain and 
essentially free of ricin B chain in a pharmaceutically acceptable 
carrier.

Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 98-23199 Filed 8-27-98; 8:45 am]
BILLING CODE 3710-08-M